ALVO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alvotech
Alvotech (ALVO)
Company Research
Source: GlobeNewswire
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Alvotech (“Alvotech” or the “Company”) (NASDAQ:ALVO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On November 3, 2025, the Company received a complete response letter (“CRL”) from the FDA for its biologics license application for AVT05. The CRL relates to a failed facility inspection which occurred in July 2025. On this news, the price of Alvotech shares declined by $2.62 per share, or approximately 34.25%, from $7.65 per share on October 31, 2025 to close at $5.03 on November 3, 2025. What Should I Do? At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws. If you purchased or otherwise acquired Alvo
Show less
Read more
Impact Snapshot
Event Time:
ALVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALVO alerts
High impacting Alvotech news events
Weekly update
A roundup of the hottest topics
ALVO
News
- Alvotech (ALVO) had its price target lowered by UBS Group AG from $10.00 to $6.00. They now have a "buy" rating on the stock.MarketBeat
- Alvotech (ALVO) had its price target lowered by Barclays PLC from $5.00 to $4.00. They now have an "underweight" rating on the stock.MarketBeat
- Alvotech (ALVO) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Did Alvotech's (ALVO) Profitability Turn and Expanding Biosimilar Pipeline Just Recast Its Investment Narrative? [Yahoo! Finance]Yahoo! Finance
- Alvotech (ALVO) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
ALVO
Earnings
- 11/12/25 - Beat
ALVO
Sec Filings
- 3/19/26 - Form 6-K
- 3/12/26 - Form SCHEDULE
- 2/27/26 - Form 6-K
- ALVO's page on the SEC website